NMR-assayable ligand-labelled trifluorothymidine containing comp

Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

424 9, 436173, 436806, 435 5, A61K 4300, A61K 4902

Patent

active

050532154

ABSTRACT:
A method for diagnosing HSV infections in human or non-human patients which involves intravenously administering to the patient a non-invasively assayable ligand-labelled anti-viral drug, wherein the drug is a compound which is phosphorylated bby the HSV-induced thymadine kinase present in HSV-infected cells to a phosphorylated assayable ligand-labelled compound which cannot diffuse from within the infected cells and then non-invasively assasying the presence or absence of the accumulated phosphorylated compound present therein.
A pharmaceutical composition in intravenously administrable form and adapted for the diagnosis of HSV infection which is a mixture of a non-invasively assayable ligand-labelled anti-viral drug and a pharmaceutically acceptable carrier therefor.

REFERENCES:
patent: 3201387 (1965-08-01), Heidelberger
patent: 4210638 (1980-07-01), Goeer
patent: 4675287 (1987-06-01), Reisfeld
Rand et al., "Trifluorothymidine: Potential Non-Invasive Diagnosis of Herpes Simplex Infection . . . ", J. Virol. Methods 18, 257-270 (1987).
Chemical Abstracts, vol. 108(13), Abst. 109067b, p. 319, 3/28/88, Hand et al., "Trifluorothymidine: Potential Non-Invasive Diagnosis of Herpes Simplex Infection . . . ", J. Virol. Methods 18(4), 257-69 (1987).
Fischer et al., Mol. Pharmacol., vol. 24, No. 1, "Preferential Inhibition of 5-Trifluoromethyl-2'-Deoxyuridine Phosphorylation by 5'-Amino-5'-Deoxythymidine in Uninfected Versus Herpes Simplex Virus-Infected Cells", pp. 90-96 (Jul. 1983).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

NMR-assayable ligand-labelled trifluorothymidine containing comp does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with NMR-assayable ligand-labelled trifluorothymidine containing comp, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and NMR-assayable ligand-labelled trifluorothymidine containing comp will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1753746

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.